Results 1 to 10 of about 10,565 (202)

Prevalence of "anti-HBc alone" among Syrian blood donors

open access: yesJournal of Infection in Developing Countries, 2014
Introduction: We aimed to evaluate the prevalence of "anti-HBc alone" among Syrian blood donors, highlighting the possibility of representing occult HBV infection.
Wael Muselmani, Wafa Habbal, Fawza Monem
doaj   +4 more sources

Serology change-based clinical interpretation of indeterminate serostatus post-hepatitis B virus infection in people living with HIV. [PDF]

open access: yesPLoS ONE
After hepatitis B virus (HBV) infection in people living with HIV (PLWH), various forms of indeterminate serostatuses, including "isolated anti-HBc (IAHBc)", are observed, but the current interpretation for their HBV immunity seems to be optimistic. This
Ei Kinai   +11 more
doaj   +2 more sources

Combined HBsAg and anti-HBc testing is required to estimate hepatitis B virus seroprevalence in a low-endemic country: findings from a nationwide population-based serosurvey, Belgium, 2020 [PDF]

open access: yesEurosurveillance
BACKGROUND The World Health Organization aims to eliminate hepatitis B virus (HBV) by 2030 through reducing incidence and mortality. Accurate prevalence estimates are crucial to guide policies and monitor progress towards HBV elimination.
Thomas Vanwolleghem
doaj   +2 more sources

Implications of occult hepatitis B infection for blood donor management: a five-year evaluation from Western Saudi Arabia [PDF]

open access: yesBMC Infectious Diseases
Background Occult hepatitis B infection (OBI), defined by detectable HBV DNA in the absence of hepatitis B surface antigen (HBsAg), remains a diagnostic challenge and a potential source of transfusion-transmitted infection.
Wajnat A. Tounsi   +9 more
doaj   +2 more sources

Prevalence of occult hepatitis B infection and hepatitis B genotype characterization among blood donors in Jember Regency, East Java, Indonesia [PDF]

open access: yesBMC Infectious Diseases
Background Despite extensive HBV vaccination efforts in Indonesia, the prevalence of occult hepatitis B virus infection (OBI) remains a concern, particularly among blood donors.
Valentinus Dave Sugiharto   +10 more
doaj   +2 more sources

Cost-effectiveness and long-term outcomes of liver transplantation using hepatitis B core antibody-positive grafts with hepatitis B immunoglobulin prophylaxis in Korea [PDF]

open access: yesClinical and Molecular Hepatology, 2021
Background/Aims Hepatitis B core antibody (anti-HBc)-positive donors are used as an extended donor pool, and current guidelines recommend the usage of nucleos(t)ide analogues (NAs) as prophylaxis for preventing de novo hepatitis B virus infection (DNH ...
Kyeong Deok Kim   +8 more
doaj   +1 more source

Seroprevalence of Hepatitis B Virus Infection among the Tribal Population of Attapady, Kerala, India [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2021
Introduction: Hepatitis B Virus (HBV) infection remains a significant global health concern that may cause acute or chronic hepatitis. Chronically infected patients are at risk for cirrhosis and hepatocellular carcinoma.
Irene Jose Manjiyil   +1 more
doaj   +1 more source

Serological and molecular characterization of hepatitis B virus infection in chronic kidney disease patients from Rio de Janeiro, Brazil

open access: yesBrazilian Journal of Infectious Diseases, 2022
Chronic kidney disease (CKD) patients undergoing hemodialysis (HD) are more vulnerable to blood-borne viral infections due to frequent invasive procedures.
Livia Melo Villar   +8 more
doaj   +1 more source

Quantitative of serum hepatitis B core antibody is a potential predictor of recurrence after interferon-induced hepatitis B surface antigen clearance

open access: yesJournal of Microbiology, Immunology and Infection, 2021
Background: Recurrence is common for patients with chronic hepatitis B (CHB) who achieved hepatitis B virus (HBV) surface antigen (HBsAg) clearance after antiviral treatment.
Yali Wu   +4 more
doaj   +1 more source

Liver transplantation for viral hepatitis in 2015 [PDF]

open access: yes, 2016
Liver transplantation (LT) is a life-saving treatment for patients with end-stage liver disease and for patients with liver cell cancer related to liver disease.
Bortoluzzi, Ilaria   +8 more
core   +1 more source

Home - About - Disclaimer - Privacy